Risk Prediction for Secondary Events in Adults with Arteriosclerotic Cardiovascular Disease (ASCVD)
Research Grant
Administered By
Duke Clinical Research Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 15, 2015
End Date
June 30, 2021
Administered By
Duke Clinical Research Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
December 15, 2015
End Date
June 30, 2021